VANI

Vivani Medical Inc.

VANI, USA

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.

https://www.vivani.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
VANI
stock
VANI

Is VANI stock trading near support levels - Portfolio Return Report & Expert Verified Movement Alerts Улправда

Read more →
VANI
stock
VANI

Gregg Williams Purchases 1,737,765 Shares of Vivani Medical (NASDAQ:VANI) Stock Defense World

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$4

Analyst Picks

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very High

64.32

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-498.85 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-26.07 %

Low ≤ 2%

High ≥ 10%

Debt to Equity

-

Very Low

18.13

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 9.86% of the total shares of Vivani Medical Inc.

1.

Vanguard Group Inc

(2.4181%)

since

2025/06/30

2.

Tanager Wealth Management LLP

(1.7237%)

since

2025/06/30

3.

Vanguard Total Stock Mkt Idx Inv

(1.0632%)

since

2025/07/31

4.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8843%)

since

2025/07/31

5.

Geode Capital Management, LLC

(0.5974%)

since

2025/06/30

6.

Commonwealth Equity Services Inc

(0.5579%)

since

2025/06/30

7.

Monetary Management Group Inc

(0.3274%)

since

2025/06/30

8.

Fidelity Extended Market Index

(0.2769%)

since

2025/07/31

9.

State Street Corp

(0.2174%)

since

2025/06/30

10.

CI Private Wealth LLC

(0.1692%)

since

2025/06/30

11.

EVOKE WEALTH, LLC

(0.1686%)

since

2025/06/30

12.

Sabby Management LLC

(0.1584%)

since

2025/06/30

13.

BlackRock Inc

(0.1492%)

since

2025/06/30

14.

iShares Micro-Cap ETF

(0.123%)

since

2025/08/31

15.

Northern Trust Corp

(0.1214%)

since

2025/06/30

16.

Fidelity Total Market Index

(0.087%)

since

2025/07/31

17.

Spartan Extended Market Index Pool F

(0.0684%)

since

2025/07/31

18.

Fidelity Series Total Market Index

(0.0671%)

since

2025/07/31

19.

NT Ext Equity Mkt Idx Fd - L

(0.0643%)

since

2025/06/30

20.

Northern Trust Extended Eq Market Idx

(0.0643%)

since

2025/06/30

21.

Fidelity Nasdaq Composite Index

(0.0635%)

since

2025/07/31

22.

NT Ext Equity Mkt Idx Fd - NL

(0.054%)

since

2025/06/30

23.

Charles Schwab Investment Management Inc

(0.0507%)

since

2025/06/30

24.

Schwab Total Stock Market Index

(0.0507%)

since

2025/07/31

25.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0419%)

since

2025/06/30

26.

Spartan Total Market Index Pool G

(0.0342%)

since

2025/07/31

27.

Panagora Asset Management Inc

(0.0329%)

since

2025/06/30

28.

Jane Street Group LLC

(0.0297%)

since

2025/06/30

29.

Vanguard U.S. Eq Idx £ Acc

(0.0275%)

since

2025/07/31

30.

Susquehanna International Group, LLP

(0.0272%)

since

2025/06/30

31.

Goldman Sachs Group Inc

(0.0243%)

since

2025/06/30

32.

UBS Group AG

(0.02%)

since

2025/06/30

33.

Extended Equity Market Fund K

(0.0198%)

since

2025/06/30

34.

TWO SIGMA SECURITIES, LLC

(0.0187%)

since

2025/06/30

35.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0181%)

since

2025/06/30

36.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0153%)

since

2024/12/31

37.

State St US Extended Mkt Indx NL Cl C

(0.0119%)

since

2025/08/31

38.

1290 VT Micro Cap K

(0.0103%)

since

2025/07/31

39.

SBI Securities Co Ltd

(0.0034%)

since

2025/06/30

40.

Headlands Technologies LLC

(0.003%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.09

Latest Release

Date

2025-09-30

EPS Actual

-0.11

EPS Estimate

-0.095

EPS Difference

-0.015

Surprise Percent

-15.7895%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(1.5)
Defensive
Moderately Defensive(5)
Dividend
Weak Dividend Profile(1)
Economic Moat
No Clear Moat(2.8)
GARP
Not Attractive for GARP(0.5)
Growth
Weak Growth Prospect(0.5)
Momentum
No Momentum(2.5)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Low Quality Business(1)
Value
Overpriced(1.5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.